Clinical Trials Logo

PSEN1 Mutation clinical trials

View clinical trials related to PSEN1 Mutation.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04413344 Completed - Clinical trials for Familial Alzheimer Disease (FAD)

Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease

REBRAnD
Start date: June 5, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

To investigate the safety and efficacy of an orally administered dose of TW-012R in patients with Alzheimer's disease bearing PSEN1 (presenilin 1) mutations (PSEN1-AD), using a placebo group as a control. In addition, long-term safety will be examined in an open-label extension trial.